M. Kathleen Behrens, Ph.D.
Board Member
Sarepta Therapeutics, Inc. (SRPT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About M. Kathleen Behrens, Ph.D.
M. Kathleen Behrens, Ph.D. is recorded as Board Member at Sarepta Therapeutics, Inc. (SRPT). Sarepta Therapeutics, Inc. reported in an 8-K filed June 6, 2025 that M. Kathleen Behrens, Ph.D. was appointed director, effective June 5, 2025. Sarepta Therapeutics, Inc. reported in an 8-K filed June 9, 2023 that M. Kathleen Behrens, Ph.D. was appointed Director (Class II), effective June 8, 2023.
“The director nominees listed below were elected to serve on the Company’s board of directors as members of Class II for a term of two years.”
“The director nominees listed below were elected to serve on the Company’s board of directors as members of Class II for a term of two years.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sarepta Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Douglas Ingram CEO, Board Member
- Michael Severino, M.D. CEO, Board Member
- M. Kathleen Behrens Chairman
- Ryan H. Wong CFO
- Ian Estepan COO, Chief Accounting Officer
- Ian M. Estepan COO
- Cristin L. Rothfuss General Counsel
- Claude Nicaise Board Member
- Claude Nicaise, M.D. Board Member
- Deirdre Connelly Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.